Luken Investment Analytics, LLC Astrazeneca PLC Transaction History
Luken Investment Analytics, LLC
- $216 Billion
- Q4 2024
A detailed history of Luken Investment Analytics, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Luken Investment Analytics, LLC holds 1,500 shares of AZN stock, worth $112,395. This represents 0.05% of its overall portfolio holdings.
Number of Shares
1,500
Previous 1,500
-0.0%
Holding current value
$112,395
Previous $117 Million
15.9%
% of portfolio
0.05%
Previous 0.05%
Shares
1 transactions
Others Institutions Holding AZN
# of Institutions
1,368Shares Held
512MCall Options Held
6.08MPut Options Held
4.44M-
Price T Rowe Associates Inc Baltimore, MD60.4MShares$4.52 Billion0.46% of portfolio
-
Primecap Management CO Pasadena, CA41MShares$3.07 Billion2.12% of portfolio
-
Capital International Investors Los Angeles, CA37.5MShares$2.81 Billion0.48% of portfolio
-
Bank Of America Corp Charlotte, NC24MShares$1.8 Billion0.13% of portfolio
-
Franklin Resources Inc San Mateo, CA19.5MShares$1.46 Billion0.37% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $232B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...